Meisoindigo TAC CRABP-II Degrader-1 EED inhibitor1

EED inhibitor1

is discovered to inhibit JNK kinase by broad-base kinase selectivity profiling of a library of acrylamide kinase inhibitors based on the structure of imatinib using the KinomeSca approach

SB505124 (10 µM) impairs Smad2 phosphorylation and CTGF and α-SMA expression in vitro

35 mg/mL (14

1956356-56-1

Meisoindigo TAC CRABP-II Degrader-1 EED inhibitor1Meisoindigo, also known as N Methylisoindigotin and Dian III, is an apoptosis inducer and potential agent for AML. Meisoindigo has been a routine therapeutic agent in the clinical treatment of chronic myelogenous leukemia (CML) in China since the 1980s. Meisoindigo is a promising agent with in vitro and in vivo activity against human acute myeloid leukemia. Product information CAS Number: 97207 47 1 Molecular Weight: 276. 29 Formula: C17H12N2O2